A citation-based method for searching scientific literature

Tae Kon Kim, Esten N Vandsemb, Roy S Herbst, Lieping Chen. Nat Rev Drug Discov 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease.
Weili Wang, Lei Huang, Jian-Yue Jin, Wenhu Pi, Susannah G Ellsworth, Shruti Jolly, Andrew L Mellor, Mitchell Machtay, Feng-Ming Spring Kong. Clin Cancer Res 2020
10
100

Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics.
Sophia K Longo, Margaret G Guo, Andrew L Ji, Paul A Khavari. Nat Rev Genet 2021
78
100

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch,[...]. J Immunother Cancer 2020
249
100

A review of cancer immunotherapy toxicity.
Lucy Boyce Kennedy, April K S Salama. CA Cancer J Clin 2020
294
100

Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.
Nathalie M Schmidt, Peter A C Wing, Mariana O Diniz, Laura J Pallett, Leo Swadling, James M Harris, Alice R Burton, Anna Jeffery-Smith, Nekisa Zakeri, Oliver E Amin,[...]. Nat Commun 2021
11
100

High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells.
Ting Liu, Jizhou Tan, Minhao Wu, Wenzhe Fan, Jialiang Wei, Bowen Zhu, Jian Guo, Shutong Wang, Penghui Zhou, Hui Zhang,[...]. Gut 2021
21
100

Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Jin-Ching Lin, Kuang Y Chen, Wen-Yi Wang, Jian-Sheng Jan, Wen-Miin Liang, Yau-Huei Wei. Int J Cancer 2002
16
100

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response.
Alexander Haragan, John K Field, Michael P A Davies, Carles Escriu, Aaron Gruver, John R Gosney. Lung Cancer 2019
60
100

Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.
Vesselina G Cooke, Valerie S LeBleu, Doruk Keskin, Zainab Khan, Joyce T O'Connell, Yingqi Teng, Michael B Duncan, Liang Xie, Genta Maeda, Sylvia Vong,[...]. Cancer Cell 2012
365
100


Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
Kevin C Conlon, Enrico Lugli, Hugh C Welles, Steven A Rosenberg, Antonio Tito Fojo, John C Morris, Thomas A Fleisher, Sigrid P Dubois, Liyanage P Perera, Donn M Stewart,[...]. J Clin Oncol 2015
388
100

Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Masato Nakamura, Hiroaki Nagano, Masato Sakon, Tameyoshi Yamamoto, Hideo Ota, Hiroshi Wada, Bazarragchaa Damdinsuren, Takehiro Noda, Shigeru Marubashi, Atsushi Miyamoto,[...]. J Hepatol 2007
58
100

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.
David R Spigel, Jamie E Chaft, Scott Gettinger, Bo H Chao, Luc Dirix, Peter Schmid, Laura Q M Chow, Rodney J Hicks, Larry Leon, Jill Fredrickson,[...]. J Thorac Oncol 2018
76
100


Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models.
Nicholas L Syn, Pei Li Lim, Li Ren Kong, Lingzhi Wang, Andrea Li-Ann Wong, Chwee Ming Lim, Thomas Kwok Seng Loh, Gerhard Siemeister, Boon Cher Goh, Wen-Son Hsieh. Signal Transduct Target Ther 2018
24
100

CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.
Zahra Madjd, Ali Zare Mehrjerdi, Ali Mohammad Sharifi, Saadat Molanaei, Shahriar Zohourian Shahzadi, Mohsen Asadi-Lari. Cancer Immun 2009
71
100

Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies.
Rodolfo Daniel Cervantes-Villagrana, Damaris Albores-García, Alberto Rafael Cervantes-Villagrana, Sara Judit García-Acevez. Signal Transduct Target Ther 2020
45
100

Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.
Terence Kin-Wah Lee, Xin-Yuan Guan, Stephanie Ma. Nat Rev Gastroenterol Hepatol 2022
20
100

Next generation of immune checkpoint inhibitors and beyond.
Julian A Marin-Acevedo, ErinMarie O Kimbrough, Yanyan Lou. J Hematol Oncol 2021
55
100

TOX is a critical regulator of tumour-specific T cell differentiation.
Andrew C Scott, Friederike Dündar, Paul Zumbo, Smita S Chandran, Christopher A Klebanoff, Mojdeh Shakiba, Prerak Trivedi, Laura Menocal, Heather Appleby, Steven Camara,[...]. Nature 2019
368
100

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.
Omar Khan, Josephine R Giles, Sierra McDonald, Sasikanth Manne, Shin Foong Ngiow, Kunal P Patel, Michael T Werner, Alexander C Huang, Katherine A Alexander, Jennifer E Wu,[...]. Nature 2019
462
100

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy.
Kai Tang, Ya-Hong Wu, Yihui Song, Bin Yu. J Hematol Oncol 2021
33
100

Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.
James L Gulley, Jeffrey Schlom, Mary Helen Barcellos-Hoff, Xiao-Jing Wang, Joan Seoane, Francois Audhuy, Yan Lan, Isabelle Dussault, Aristidis Moustakas. Mol Oncol 2022
6
100

T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.
Jin Bian, Jianzhen Lin, Junyu Long, Xu Yang, Xiaobo Yang, Xin Lu, Xinting Sang, Haitao Zhao. Am J Cancer Res 2020
13
100

Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer.
Lujun Zhao, Wei Ji, Li Zhang, Guangfei Ou, Qinfu Feng, Zongmei Zhou, Mingfang Lei, Weizhi Yang, Luhua Wang. J Thorac Oncol 2010
29
100

High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients.
Ana Koren, Matija Rijavec, Eva Sodja, Izidor Kern, Aleksander Sadikov, Viljem Kovac, Peter Korosec, Tanja Cufer. Oncotarget 2017
4
100

Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy.
Satyen H Gohil, J Bryan Iorgulescu, David A Braun, Derin B Keskin, Kenneth J Livak. Nat Rev Clin Oncol 2021
46
100

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges.
Yu Chen, Min Gao, Zhaoqin Huang, Jinming Yu, Xiangjiao Meng. J Hematol Oncol 2020
22
100

The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Liu Li, Qiu Guo Chao, Liu Zhong Ping, Chen Xue, Zhao Yan Xia, Ding Qian, Huang Shi-ang. Cancer Biother Radiopharm 2009
33
100

Trajectory and Functional Analysis of PD-1high CD4+CD8+ T Cells in Hepatocellular Carcinoma by Single-Cell Cytometry and Transcriptome Sequencing.
Bo Zheng, Dongfang Wang, Xinyao Qiu, Guijuan Luo, Tong Wu, Shuai Yang, Zhixuan Li, Yanjing Zhu, Shan Wang, Rui Wu,[...]. Adv Sci (Weinh) 2020
24
100

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Yang Hao, David Baker, Peter Ten Dijke. Int J Mol Sci 2019
337
100

Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Guoying Zhou, Dave Sprengers, Patrick P C Boor, Michail Doukas, Hannah Schutz, Shanta Mancham, Alexander Pedroza-Gonzalez, Wojciech G Polak, Jeroen de Jonge, Marcia Gaspersz,[...]. Gastroenterology 2017
211
100

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.
Ashley Maynard, Caroline E McCoach, Julia K Rotow, Lincoln Harris, Franziska Haderk, D Lucas Kerr, Elizabeth A Yu, Erin L Schenk, Weilun Tan, Alexander Zee,[...]. Cell 2020
116
100

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Filipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, Faiza Lamine, Michel Maillard, Montserrat Fraga, Keyvan Shabafrouz, Camillo Ribi, Anne Cairoli, Yan Guex-Crosier,[...]. Nat Rev Clin Oncol 2019
581
100

Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
Shulian Wang, Jeff Campbell, Matthew H Stenmark, Jing Zhao, Paul Stanton, Martha M Matuszak, Randall K Ten Haken, Feng-Ming Spring Kong. Int J Radiat Oncol Biol Phys 2017
34
100

Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Karsten A Pilones, Maud Charpentier, Elena Garcia-Martinez, Camille Daviaud, Jeffrey Kraynak, Joseph Aryankalayil, Silvia C Formenti, Sandra Demaria. Cancer Immunol Res 2020
12
100

Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer.
Juliana Matiello, Alan Dal Pra, Laise Zardo, Ricardo Silva, Danilo C Berton. Thorac Cancer 2020
6
100

Emerging agents that target signaling pathways in cancer stem cells.
Yue Yang, Xiaoman Li, Ting Wang, Qianqian Guo, Tao Xi, Lufeng Zheng. J Hematol Oncol 2020
51
100

Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer.
Edwin Pun Hui, Brigette B Y Ma, W K Jacky Lam, K C Allen Chan, Frankie Mo, Qi-Yong Hemis Ai, Ann D King, Chi Hang Wong, Kenneth C W Wong, Daisy C M Lam,[...]. Clin Cancer Res 2021
7
100


The Next Decade of Immune Checkpoint Therapy.
Padmanee Sharma, Bilal A Siddiqui, Swetha Anandhan, Shalini S Yadav, Sumit K Subudhi, Jianjun Gao, Sangeeta Goswami, James P Allison. Cancer Discov 2021
83
100

Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Aparna Jayachandran, Bijay Dhungel, Jason C Steel. J Hematol Oncol 2016
111
100

Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Yanan Gao, Maojun You, Junliang Fu, Meijie Tian, Xinyue Zhong, Chengzhi Du, Zhixian Hong, Zhenyu Zhu, Junliang Liu, Geoffrey J Markowitz,[...]. J Hepatol 2022
11
100

Metastatic cells will take any help they can get.
Richard O Hynes. Cancer Cell 2011
9
100

Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.
Yanmei Han, Qiuyan Liu, Jin Hou, Yan Gu, Yi Zhang, Zhubo Chen, Jia Fan, Weiping Zhou, Shuangjian Qiu, Yonghong Zhang,[...]. Cell 2018
68
100

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
T Lapidot, C Sirard, J Vormoor, B Murdoch, T Hoang, J Caceres-Cortes, M Minden, B Paterson, M A Caligiuri, J E Dick. Nature 1994
100

Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.
Sophia Heinrich, Amanda J Craig, Lichun Ma, Bernd Heinrich, Tim F Greten, Xin W Wang. J Hepatol 2021
16
100

RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy.
Ziyou Lin, Yi Niu, Arabella Wan, Dongshi Chen, Heng Liang, Xijun Chen, Lei Sun, Siyue Zhan, Liutao Chen, Chao Cheng,[...]. EMBO J 2020
116
100

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade.
Youhai Jiang, Xiaofang Zhao, Jing Fu, Hongyang Wang. Front Immunol 2020
38
100

Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.
Yonit Lavin, Soma Kobayashi, Andrew Leader, El-Ad David Amir, Naama Elefant, Camille Bigenwald, Romain Remark, Robert Sweeney, Christian D Becker, Jacob H Levine,[...]. Cell 2017
634
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.